Noel Stevens
Acute Care · Pikesville, MDNPI 1699914358
Payments from drug & device makers
Across 70 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$403
- AstraZeneca$300
- AbbVie$133
- Bayer$91
- Tactile Systems Technology Inc$88
- Astellas Pharma US Inc$65
- plus $346 from 13 others
What the payments were for
- Food & beverage$1,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $403 |
| AstraZeneca | 6 | $300 |
| AbbVie | 6 | $133 |
| Bayer | 4 | $91 |
| Tactile Systems Technology Inc | 3 | $88 |
| Astellas Pharma US Inc | 2 | $65 |
| Lilly USA, LLC | 3 | $50 |
| Amgen(2 entities) | 2 | $41 |
| Merck | 2 | $40 |
| GSK | 2 | $36 |
| Corcept Therapeutics | 2 | $35 |
| Exact Sciences | 1 | $23 |
| TMS Neurohealth Centers Inc. | 1 | $21 |
| Vertex | 1 | $19 |
| Medtronic | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Optinose US, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,426 in reported general payments places this provider in the 85th percentile of 502 acute care providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 147 | $1,556 |
| Rosuvastatin Calcium | 28 | $701 |
| Atorvastatin Calcium | 33 | $486 |
| Methylprednisolone | 77 | $414 |
| Metoprolol Succinate | 21 | $401 |
| Pantoprazole Sodium | 22 | $256 |
| Doxycycline Monohydrate | 41 | $202 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $185 |
| Amlodipine Besylate | 28 | $159 |
| ValacyclovirValacyclovir Hcl | 14 | $125 |
| Gabapentin | 28 | $104 |
| Prednisone | 15 | $94 |
| Meloxicam | 29 | $79 |
| Cefdinir | 11 | $77 |
| Lisinopril | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other acute care in Pikesville
- Paige GriffithBaltimore$106K
- Amanda ReaPerry Hall$65K
- T Nicole KelleyBaltimore$46K
- Amy GoodrichBaltimore$27K
- Rama AnthonyBaltimore$20K
- Susan HuppmannBaltimore$16K
- Tammy SlaterBaltimore$12K
- Eleanor DunlapBaltimore$11K
- Tierra AndersonTakoma Park$9K
- Lateaqua AlstonBaltimore$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.